Please login to the form below

cladribine

This page shows the latest cladribine news and features for those working in and with pharma, biotech and healthcare.

despite greater competition from drugs like Roche’s Ocrevus (ocrelizumab), Novartis’ Mayzent (siponimod) and Merck KGaA’s Mavenclad (cladribine).

MS and cholesterol drugs picked for new UK rapid uptake push

Merck’s Mavenclad (cladribine) for treating highly active relapsing-remitting multiple sclerosis in adults - A drug for multiple sclerosis with a novel mode of action, high efficacy and a low treatment
Sanofi licences Principia MS drug in $805m deal

The three established players in the oral MS therapy category are also about to see additional competition from new entrant Merck KGaA, which bagged EU approval for Mavenclad (cladribine) in August.
Merck mulls sale of consumer health division

The news comes a few days after Merck picked up an important new approval for its pharma division in Europe, with the EMA clearing Mavenclad (cladribine) for the treatment of
Merck gets CHMP backing for long-delayed oral MS drug

Cladribine, which will be branded as Mavenclad, was originally rejected by the committee in 2010. ... The company thinks oral cladribine has a key differentiator from its rivals, which require daily dosing.
Avelumab costs peg back profit at Merck KGaA

Avelumab and other pipeline candidates such as oral MS therapy cladribine have assumed even more importance for Merck since it abandoned plans to seek approval of evofosfamide in advanced soft tissue

More from news
Approximately 2 fully matching, plus 26 partially matching documents found.

XenoPort appoints chief medical officer

Prior to joining Biogen Idec Dr Kim was with Merck Serono, serving as medical director for the phase III programme of cladribine, which failed to impress in MS.

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Account Director, Medical & Brand Communications, London/ SE...: Highly competitive salary

Freelance Scientific Director, Medical Communications, London/ S...: Highly competitive salary

Editorial Director - UK, , EUROPE, REMOTE.: Highly Competitive Salary, Bonus &Benefits

Senior Account Management Trainer, Medical Communications, Londo...: Highly competitive salary

Senior Account Director, Medical & Brand Communications, Lon...: Highly competitive salary

Home Working Medical Copy Writer & Senior Medical Copy Write...: Highly Competitive Salary, Bonus &Benefits

Medical Writer, Women’s health, Medical Communications agency, h...: Highly competitive salary

Medical Writers (All levels) Editorial / Scientific Leads & ...: Highly Competitive Remuneration packages

Entry Level Account Executive – Healthcare Advertising – London...: Salary TBC

Add my company

Seven Stones is a creative, independent healthcare communications agency of movers and thinkers. We've been doing health differently since 1991....

Robust Review: COVID19 Assessment: See how our client utilized Rapid Payer Response (RPR) to stay informed and gain continuous insights during the recent global pandemic (COVID19)...
All change – how untangling human behaviour can encourage better health: Driving better patient outcomes through clear, achievable practical steps that are underpinned by transparent evidence...
Health literacy in the time of COVID-19: In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...

Email:
Password: